CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- 4 Gift Chief Medical Officer gave 1,909,585 shares (gift)
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Delisting notice
- SC 13D/A Stake Beneficial Ownership Report
- 4 Gift Director gave 567,871 shares (gift)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Executive or director change
Page 15 of 50 · 996 filings